Basic information Safety Supplier Related
ChemicalBook >  Product Catalog >  Pharmaceutical intermediates >  Heterocyclic compound >  Pyridine compound >  Aminopyridine >  tert-butyl 4-(6-aMinopyridin-3-yl)piperidine-1-carboxylate

tert-butyl 4-(6-aMinopyridin-3-yl)piperidine-1-carboxylate

Basic information Safety Supplier Related

tert-butyl 4-(6-aMinopyridin-3-yl)piperidine-1-carboxylate Basic information

Product Name:
tert-butyl 4-(6-aMinopyridin-3-yl)piperidine-1-carboxylate
Synonyms:
  • tert-butyl 4-(6-aMinopyridin-3-yl)piperidine-1-carboxylate
  • tert-Butyl 4-(6-aminopyridin-3-yl)
  • 4-(6-Amino-3-pyridyl)-1-Boc-piperidine
  • 1-Piperidinecarboxylic acid, 4-(6-amino-3-pyridinyl)-, 1,1-dimethylethyl ester
  • ert-butyl4-(6-aminopyridin-3-yl)piperidine-1-carboxylate
  • tert-butyl 4-(6-aMinopyridin-3-yl)piperidine-1-carboxylate ISO 9001:2015 REACH
  • 6-amino-3',4',5',6'-tetrahydro-2'H-[3,4']bipyridinyl-1'-carboxylicacidtert-butylester
  • 4-(6-aminopyridin-3-yl)piperidine-1-carboxylate
CAS:
1198408-35-3
MF:
C15H23N3O2
MW:
277.36
Mol File:
1198408-35-3.mol
More
Less

tert-butyl 4-(6-aMinopyridin-3-yl)piperidine-1-carboxylate Chemical Properties

Boiling point:
422.8±45.0 °C(Predicted)
Density 
1.134±0.06 g/cm3(Predicted)
storage temp. 
2-8°C(protect from light)
pka
6.80±0.26(Predicted)
Appearance
Off-white to light yellow Solid
InChI
InChI=1S/C15H23N3O2/c1-15(2,3)20-14(19)18-8-6-11(7-9-18)12-4-5-13(16)17-10-12/h4-5,10-11H,6-9H2,1-3H3,(H2,16,17)
InChIKey
UGJYTOMOCDGLRS-UHFFFAOYSA-N
SMILES
N1(C(OC(C)(C)C)=O)CCC(C2=CC=C(N)N=C2)CC1
More
Less

tert-butyl 4-(6-aMinopyridin-3-yl)piperidine-1-carboxylate Usage And Synthesis

Synthesis

1231930-22-5

1198408-35-3

In a 500 mL round-bottomed flask, tert-butyl 4-(6-nitropyridin-3-yl)-5,6-dihydropyridine-1(2H)-carboxylate (4.9 g, 16.0 mmol, 1.00 equiv.) was dissolved in a solvent mixture of ethanol (300 mL) and ethyl acetate (75 mL) and palladium carbon (1.32 g, 1.24 mmol, 0.0773 equiv.) was added. The reaction mixture was displaced twice with hydrogen and then stirred overnight under a hydrogen atmosphere (using a hydrogen balloon). The completion of the reaction was confirmed by LC/MS analysis. The reaction mixture was purged with nitrogen and filtered through a diatomaceous earth pad, which was washed several times with ethyl acetate. The colorless filtrate and washings were combined, dichloromethane was added and the solution was evaporated to dryness. Dichloromethane was added again and the solution was concentrated under vacuum to give the target product tert-butyl 4-(6-aminopyridin-3-yl)piperidine-1-carboxylate in quantitative yield. (M + H)+ = 278 m/z.

References

[1] Patent: WO2013/24078, 2013, A1. Location in patent: Page/Page column 57; 58
[2] Patent: CN106608879, 2017, A. Location in patent: Paragraph 0268-0269; 0273-0274
[3] Patent: WO2014/83026, 2014, A1. Location in patent: Page/Page column 26; 47-48
[4] Patent: CN105622638, 2016, A. Location in patent: Paragraph 0181
[5] Patent: US2018/297995, 2018, A1. Location in patent: Paragraph 0046; 0051; 0052

tert-butyl 4-(6-aMinopyridin-3-yl)piperidine-1-carboxylateSupplier

Suzhou Ningrui Pharmaceutical Co., Ltd Gold
Tel
0512-18261440723
Email
2149720772@qq.com
SuZhou Medinoah Co.,LTD. Gold
Tel
0512-69561983 13914027025
Email
zhang_q@medinoah.com
Lead Biotech (Hangzhou) Co., Ltd Gold
Tel
0571-56190693 18657131631
Email
jian.wang@leadbiotech.com
Shanghai Moss Medicine Technology Co., Ltd. Gold
Tel
+86-188369842 +86-15618151133
Email
188369842@qq.com
Carbott PharmTech Inc.
Tel
0535-6385396
Email
info@carbottpharm.com